Related case:
ADDPI 2017_21 INADA vs Davinder Singh Kang
April 23, 2018
In May 2018 the International Association of Athletics Federations (IAAF) has reported an anti-doping rule violation against the Indian Athlete Davinder Singh Kang after his A and B samples tested positive for the prohibited substances 5α-Adiol and 5β-Adiol.
After notification the Athlete filed a statement in his defence and he was scheduled to be heard for the IAAF Disciplinary Tribunal.
On 14 February 2019, the World Anti-Doping Agency (WADA) advised the IAAF that it was conducting a review of the analytical performance of the New Delhi Laboratory, including in connection with the Adverse Analytical Finding. In light of this ongoing review, WADA suggested to the IAAF, in the interest of fairness to the parties, that the Athlete's hearing be adjourned whilst WADA completed its review of the Laboratory.
On 1 March 2019, the New Delhi Laboratory and WADA reported that the issued AAF was withdrawn after review of the analytical results. WADA considered the case closed and notified the IAAF to discontinue the disciplinary proceedings against the Athlete with immediate effect.
On 7 March 2019 the IAAF Athletics Integrity Unit (AIU) decided to withdraw its Notice of Charge and to acquit the Athlete.